HDL Cholesterol in Athletes: What Your “Good Cholesterol” Actually Tells You
Table of Contents
Introduction: Why HDL Cholesterol in Athletes Needs a Different Framework
In cholesterol discussions, the older public narrative was often simplified into the idea that all cholesterol was bad. Today, many patients are at least aware of the distinction between “good” and “bad” cholesterol — usually meaning HDL cholesterol and LDL cholesterol. In athletes, this distinction becomes even more interesting, because endurance-trained individuals often have higher HDL-C levels on average than sedentary controls.
Exercise training is associated with increases in HDL-C. A large-scale meta-analysis of 148 randomized controlled trials including 8,673 participants found that high-density lipoprotein cholesterol (HDL) increased by a mean difference of 2.11 mg/dL (95% CI 1.43, 2.79) following exercise training [1]. In small studies of endurance-trained men, HDL-C differences compared with sedentary controls were larger than the average HDL-C change seen in general exercise-training RCTs, and the mechanisms behind them reveal something important about how exercise actually protects the cardiovascular system.
In this article, I will examine what cholesterol means for athletes and why its interpretation requires more nuance than simply labeling one value as “good” and another as “bad.” I will focus especially on HDL cholesterol, how training can influence it, and why an athlete’s lipid profile should be interpreted in the context of sport type, training history, and overall cardiovascular risk.
Why Endurance Athletes Have Higher HDL Cholesterol Than Sedentary Controls
The gap between athletes and sedentary individuals is well-documented in small controlled studies. A metabolic study comparing 10 endurance athletes to 10 sedentary men maintained on identical diets found that HDL cholesterol was 58±14 versus 41±10 mg/dL, and HDL2 cholesterol — a larger, lipid-rich HDL subfraction — was 26±10 versus 12±8 mg/dL [2]. Apolipoprotein A-I (apo A-I) was also higher: 144±18 versus 115±22 mg/dL [2].
What drives this difference? Not increased HDL production — that study found no differences in HDL apoprotein synthetic rates between groups [2]. Instead, athletes catabolize HDL more slowly. The catabolic rates of both apo A-I (0.15±0.02 versus 0.22±0.05 pools per day, p<0.01) and apolipoprotein A-II (apo A-II) (0.15±0.02 versus 0.20±0.04 pools per day, p<0.05) were reduced in the trained men [2].
The enzymatic picture is further illustrated by a study of five trained men who ran 16 km daily and five inactive men: the mean HDL cholesterol level was 65 mg/dL in the runners and 41 mg/dL in the controls [3]. The lipid-rich HDL2 species accounted for a much higher proportion of the HDL in runners (49% v 29%) [3]. The mean biologic half-life of HDL proteins was 6.2 days in the runners compared with 3.8 days in the sedentary men [3]. The activity of lipoprotein lipase was 80% higher in the postheparin plasma of the runners, whereas the activity of hepatic triglyceride hydrolase was 38% lower [3].
It is well established that physically active people, and especially endurance-trained athletes, often have more favorable lipid profiles than sedentary individuals. This is not explained by diet alone. Regular exercise itself can improve several aspects of the lipid profile, including HDL-C, triglycerides, and overall cardiometabolic risk.
This is also why, in clinical practice, I usually encourage patients to think beyond dietary control alone. Nutrition matters, but it is only one part of the picture. When cholesterol values remain unfavorable despite several months of lifestyle changes — for example after a six-month period of dietary adjustment, weight management when relevant, and increased physical activity — medication such as statin therapy may eventually become appropriate depending on the patient’s total cardiovascular risk, LDL-C level, age, comorbidities, family history, and guideline-based treatment thresholds.
HDL Cholesterol Function in Athletes: Why the Number Alone Is Not Enough
The traditional view — higher HDL cholesterol equals more cardiovascular protection — has been substantially revised. Exercise, apart from inducing quantitative alterations in serum lipids, exerts a beneficial impact on HDL particle maturation, composition and functionality [4]. This functional dimension is what standard lipid panels cannot directly measure.
One major proposed atheroprotective function of HDL is reverse cholesterol transport: accepting cholesterol from macrophages in the artery wall and transporting it to the liver for excretion [4]. The initial step — macrophage cholesterol efflux capacity (CEC) — is considered a key mechanism by which HDL exhibits protection against atherosclerosis [4]. Exercise improves HDL functionality, including aspects of cholesterol efflux, but the effect is dose-dependent: higher amounts of aerobic exercise are generally required for measurable improvements in certain indices of CEC [4].
Beyond reverse cholesterol transport, HDL also has anti-inflammatory, antioxidative, and antithrombotic properties [4]. Just as liver enzymes in athletes or HbA1c in athletes can be systematically misread when general reference ranges are applied, HDL cholesterol in athletes is best interpreted with functional and clinical context that a standard lipid panel concentration alone cannot provide.
In practice, when lifestyle interventions work, I often see the lipid profile improve as a whole rather than through one isolated marker. With dietary changes and increased exercise, HDL-C may rise, but at the same time LDL-C and total cholesterol often come down. These changes tend to move in the same favorable direction when the intervention is effective.
This is why I try not to focus on HDL-C as a single number. A rising HDL-C can be encouraging, but it is much more meaningful when it appears together with lower LDL-C, lower total cholesterol, improved triglycerides, and a better overall cardiovascular risk profile. In other words, the goal is not simply to “raise good cholesterol,” but to improve the full lipid pattern.
The Dose-Response Relationship: How Much Training Raises HDL Cholesterol in Athletes?
Not all exercise produces the same HDL cholesterol response. Sarzynski et al. summarize prior literature as suggesting that a dose-response relationship exists between exercise training volume and changes in HDL-C, with an exercise threshold of roughly 1200 to 2200 kcal/week to elicit favorable changes in HDL-C [5]. Below this approximate range, HDL-C responses appear less consistent.
The existing literature indicates that exercise volume, rather than intensity, has the greatest influence on the HDL-C profile, though Sarzynski et al. suggest that exercise intensity may be more important than volume in terms of improving cholesterol efflux capacity [5]. A meta-analysis of 148 RCTs confirmed that combined training (aerobic + resistance) was optimal for dyslipidemia management, and that in meta-regression, each minute of session time produced an additional 2.11 mg/dL HDL increase [1].
These findings support considering training history when interpreting HDL-C and the broader lipid profile. For related discussion of training-sensitive biomarkers, see the T:C ratio in overtraining and cortisol and overtraining articles.
In clinical practice, I often see lifestyle changes happening across several areas at the same time. When patients improve their habits, the laboratory results may begin to move in a better direction, but the motivation often comes from something more tangible. They may notice that their fitness is improving, their weight is decreasing, they recover better, or everyday activities feel easier.
This matters because most patients are not motivated by HDL-C alone. If a person has no broader motivation for healthy lifestyle changes, isolated lipid values rarely feel meaningful enough to drive long-term behavior. But when patients begin to see progress — in their energy, fitness, weight, symptoms, or blood results — motivation often becomes easier to maintain.
For that reason, I try to frame HDL-C as one part of a wider health trajectory. The goal is not simply to improve a single cholesterol number. The goal is to help the patient move in a direction where several markers of health improve together: laboratory values, cardiovascular risk, physical capacity, body composition, and overall well-being.
HDL Cholesterol Across Sport Types: Not All Athletes Are Equal
A retrospective study of 957 Olympic athletes published in the Journal of Clinical Medicine found meaningful differences in lipid profiles across sport disciplines. Three hundred and forty-three athletes (35.8%) were dyslipidemic (LDL ≥ 115 mg/dL or LDL/HDL ≥ 1.90) [7]. Endurance athletes presented the lowest global cardiovascular risk compared to other types of sports, with a better lipid profile characterized by higher HDL-cholesterol and the lowest TG level compared to other sporting disciplines [7]. Female athletes showed a better lipid profile compared to men, with lower LDL, TG, and LDL/HDL ratios, and higher HDL cholesterol [7].
Elite athletic status does not automatically confer favorable lipid profiles across all sport types. In that same cohort, the LDL/HDL ratio was incorporated into the proposed Lipid Athlete Score as a way of identifying athletes with abnormal lipid profiles, offering useful context beyond HDL-C alone [7]. This mirrors the broader principle that no single metabolic marker tells the full story, as also discussed in the uric acid in athletes article.
In clinical practice, I also see the opposite situation quite often. A patient may be very physically active, train regularly, and appear fit, but if the dietary pattern is not supportive, the cholesterol profile may still remain unfavorable. Exercise helps, but it does not always overcome a diet that continues to drive LDL-C or total cholesterol upward.
This is why I still see nutrition as central in cholesterol management. I encourage physical activity strongly, because it improves cardiovascular health in many ways and can support a better lipid profile. But when the main clinical problem is elevated LDL-C or an unfavorable cholesterol pattern, dietary control is usually one of the most important foundations of treatment. Exercise can help, but for many patients it does not solve the problem by itself.
What Happens to HDL Cholesterol in Athletes Who Stop Training
Some HDL-C adaptations may diminish when endurance athletes stop or substantially reduce training. A review of detraining studies in endurance athletes identified a 0.9% decrease in high-density lipoprotein (HDL) type cholesterol after 6.5 days of training cessation, alongside LDL-C increases during the same detraining periods [8].
This may be clinically relevant during injury-related rest, off-season reductions in training, or other periods of training disruption. For related discussion of training-sensitive biomarkers, see cortisol and overtraining.
In clinical practice, I also see how quickly lipid values can move in the wrong direction when diet deteriorates. In some patients, an unfavorable dietary pattern can worsen the cholesterol profile over a relatively short period, sometimes within weeks. This is one reason I try to emphasize that lifestyle change should not be treated as a temporary “diet,” but as a sustainable long-term pattern.
Short-term dietary efforts can improve numbers for a while, but if the patient returns to the same habits that caused the problem, the lipid profile often drifts back in the wrong direction. For cholesterol management, the goal is not a brief period of strict control. The goal is a realistic way of eating and living that the patient can maintain for years.
This is also where medication sometimes becomes necessary. If LDL-C remains high despite realistic lifestyle changes, or if the patient’s overall cardiovascular risk is significant, statin therapy can be an effective and evidence-based way to reduce risk. I do not see statins as a replacement for healthy lifestyle habits, but in the right patient they can solve the part of the problem that lifestyle alone has not corrected.
Conclusion: Reading HDL Cholesterol in Athletes Correctly
HDL cholesterol in athletes should not be interpreted as a simple “good cholesterol” number. Endurance training is often associated with higher HDL-C, and small metabolic studies suggest that this may partly reflect training-related differences in HDL2, apoA-I, lipoprotein lipase activity, and slower HDL apoprotein catabolism. At the same time, HDL-C is only one part of the lipid profile, and its meaning depends on the wider clinical context.
In practice, I think the most useful way to read HDL-C is to place it beside LDL-C, triglycerides, total cholesterol, training history, diet, body composition, and overall cardiovascular risk. A higher HDL-C value can be encouraging, especially in an endurance-trained athlete, but it should not distract from an unfavorable LDL-C, high triglycerides, or a broader risk pattern that still needs attention. Elite athletic status does not automatically protect a person from dyslipidemia.
This is also why I rarely frame cholesterol management around one marker alone. Exercise can improve HDL-C and support cardiovascular health, but diet remains central, especially when LDL-C or total cholesterol is the main clinical problem. For some patients, sustainable lifestyle changes are enough to move the whole lipid profile in a better direction. For others, especially when LDL-C remains high or total cardiovascular risk is significant, statin therapy may be an evidence-based part of risk reduction.
The key message is that HDL cholesterol in athletes tells part of the story, not the whole story. It may reflect long-term training adaptation, but it still needs to be interpreted with the full lipid pattern, lifestyle context, and clinical risk profile. The goal is not simply to raise HDL-C, but to improve the overall cardiovascular picture in a way that is realistic, sustainable, and clinically meaningful.
References
[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC11787149/
[2] https://pubmed.ncbi.nlm.nih.gov/2060090/
[3] https://pubmed.ncbi.nlm.nih.gov/6748208/
[4] https://pmc.ncbi.nlm.nih.gov/articles/PMC10003711/
[5] https://www.ahajournals.org/doi/10.1161/ATVBAHA.117.310307
